LAC 46:XLV.6935. Mandatory Access and Review of Prescription Monitoring Program Data; Exceptions

A. Prior to initially prescribing any opioid to a patient, a prescriber or his/her delegate shall access and review the patient’s record in the PMP; and B. If opioids are prescribed to the patient for more than 90 days, the prescriber or his/her delegate shall access and review the record in the PMP at least every 90 days. C. This Section shall not apply if: 1. the drug is prescribed or administered to a hospice patient or any other patient who has been diagnosed as terminally ill; 2. the drug is prescribed or administered for the treatment of cancer-related chronic or intractable pain; 3. the drug is ordered or administered to a patient being treated in a hospital; 4. the PMP is not accessible or not functioning properly due to an electronic issue. However, the prescriber shall check the PMP after electronic accessibility has been restored and note the cause for the delay in the patient’s chart; or 5. no more than a single seven-day supply of the drug is prescribed or administered to a patient.